NVS

Novartis News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Novartis AG NVS NYSE Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.77 0.9% 85.91 20:00:00
Open Price Low Price High Price Close Price Prev Close
84.58 84.27 85.98 85.91 85.14
more quote information »

Recent News

Date Time Source Heading
1/28/202217:00QUIVRNew Senate Stock Trading data: Sen. Moore recently disclosed..
1/26/202208:00GLOBEAdaptimmune Announces Appointment of Cintia Piccina as Chief..
1/18/202210:39DJNMolecular Partners Shares Drop 14% After Novartis Deal
1/14/202209:29SEEKNovartis downgraded at Morgan Stanley on near-term concerns
1/12/202212:31VWNovartis CEO: We’re Moving Toward Filing Covid Drug From..
1/10/202211:57PRNUSNew Developments in Fight Against Blood Cancers, in Leadup..
1/10/202211:54PRNUSNew Developments in Fight Against Blood Cancers, in Leadup..
1/10/202211:30DJNMolecular Partners Shares Rise 19% After Ensovibep Trial..
1/10/202207:06DJNMolecular Partners Shares Rise 37% Premarket After Trial..
1/10/202202:09DJNNovartis, Molecular Partners Report Positive Data for..
1/04/202206:39SEEKU.S. Court of Appeals upholds validity of Novartis' Gilenya..
1/04/202202:22DJNNovartis Wins US Court Appeal After Challenge to Gilenya..
12/23/202102:26DJNNovartis Says FDA Approved Cholesterol Therapy
12/23/202102:22SEEKNovartis' Cosentyx wins FDA approval for types juvenile..
12/22/202118:59DJNNovartis Says FDA Approves Cosentyx to Treat Some Children,..
12/22/202116:42EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/22/202105:45DJNSyncona Shares Rise After Novartis Agrees to Buy Portfolio..
12/22/202105:25SEEKSandoz submits trastuzumab biosimilar marketing application..
12/22/202103:56SEEKNovartis acquires ocular gene therapy firm, Gyroscope..
12/22/202102:50DJNNovartis to Acquire Gyroscope Therapeutics for Up to $1.5..
12/20/202108:21SEEKNovartis Phase III skin disease studies miss omalizumab..
12/20/202107:09DJNNovartis Signs Deal With BeiGene on Immunotherapy for Up to..
12/20/202107:08DJNBeiGene Expands Collaboration with Novartis
12/17/202108:08EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/16/202105:50SEEKNovartis gains 4% on $15B buyback, sales expected to grow..
12/16/202101:50DJNNovartis to Buy Back Up to $15 Billion of Its Shares
12/13/202106:21SEEKNovartis' Kymriah shows strong responses in high-risk..
12/13/202106:11SEEKNovartis' Scemblix shows sustained response rate in patients..
12/10/202109:26SEEKNovartis highlights Piqray data in mid-stage breast cancer..
12/10/202108:21SEEKNovartis CEO says potential sale of Sandoz generics business..
12/10/202108:02PRNUSNovartis data highlight efficacy of Piqray® in HR+/HER2-..
12/08/202110:09SEEKNew data adds to overall survival benefit of Novartis'..
12/06/202115:03SEEKNovartis eyes pan coronavirus oral therapy - CEO
12/06/202112:56SEEKRoche completes repurchase of $53.3M shares from Novartis
12/02/202106:48SEEKNovartis expects sales growth of at least 4% until 2026..
12/02/202102:22DJNNovartis Says Top Drugs Should Fuel Sales Growth Through..
11/26/202105:27TRMNNovartis Aims to Make Healthcare Affordable in Sub-Saharan..
11/22/202107:09SEEKNovartis plans new sales approach for cholesterol lowering..
11/05/202109:52SEEKUBS downgrades Novartis to neutral due to slow top-line..
11/04/202106:43EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/04/202106:34SEEKNovartis to sell its Roche stake to Roche for over $20..
11/04/202103:03DJNNovartis to Sell Roche Stake to Roche for $20.7 Billion
11/01/202102:35DJNNovartis's Scemblix Gets FDA Approval for Two Indications in..
10/29/202114:10SEEKFDA approves Novartis chromic myeloid leukemia drug Scemblix
10/28/202109:00SEEKDoJ investigating Novartis marketing of Entresto, payments..
10/26/202109:41EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/26/202102:57DJNNovartis 3Q Earnings, Sales Grow; Announces Strategic Review..
10/26/202101:57DJNNovartis 3Q Earnings, Sales Grow; Announces Strategic Review..
10/25/202101:58DJNNovartis Cancer Drug Trial Doesn't Meet Primary Endpoints
10/22/202110:57DJNCreatd Shares Jump After Unit Signs Alexis LaRue
See more news about this stock »
Your Recent History
NYSE
NVS
Novartis
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220129 01:25:05